geneType for colorectal cancer
- GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000607896.1
- Last updated: 2023-06-13
- Test version history
- 607896.1, last updated: 2023-06-13
Clinical testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for Colorectal cancer, susceptibility to
Offered by Phenogen Sciences Laboratories
Overview
Test name
HelpThe name the laboratory assigns the test. Used as the default title of the page specific to the test.geneType for colorectal cancer
This is a clinical test intended for HelpPurposes or indications for the test. Lab-provided.: Risk Assessment
Click Indication tab for more information.
Clinician fills out requisition and submits to the lab. The lab will send a kit out to the clinician to collect saliva specimen from the patient. Kits may be stocked in office. The collected specimen is returned to the lab for processing.
Order URL HelpLink to the laboratory webpage with information about how to order this test. Please note that clicking on this link will open a new tab in your internet browser.: https://genetype.com/for-clinical-professionals-usa/how-to-order-usa/
Specimen source
Methodology
HelpThe assay's major method category (biochemical, cytogenetic or molecular genetics); method category (i.e. enzyme assay, chromosome breakage studies, targeted mutation analysis); methodology (i.e. the name of the method used) and instruments used when performing this test.- Molecular Genetics
- TTargeted variant analysis
- SNP Detection
- Illumina HiScan™SQ system
- Illumina custom beadarray
Sufficient research has not been conducted to demonstrate the utility of the test
Clinical validity
HelpHow consistently and accurately the test detects or predicts the intermediate or final outcomes of interest. Lab-provided.Assessment of clinical validity of a colorectal cancer risk model combining genetic and clinical information
- Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank. - PubMed ID: 34525106
Testing strategy
HelpThe lab's suggested sequence of ordering tests based on clinical scenarios. It may include information on: reflex testing including each test component, and scenarios which prompt additional components of testing; whether lab communicates interim results or automatically proceeds to further analyses; and if any components are performed in another laboratory.Colorectal cancer risk assessment testing is available to general population women who are NOT carriers of a pathogenic variant associated with breast cancer susceptibility. 000 Clinician fills out requisition and submits to the lab. The lab will send a kit out to the clinician to collect saliva specimen from the patient. Kits may be stocked in office. The collected specimen is returned to the lab for processing.
Test services
HelpLaboratory's order or catalog code for the test (used in the order requisition form).- Clinical Testing/Confirmation of Mutations Identified Previously
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.